Medtronic is cutting its fourth quarter earnings guidance as it absorbs research and development costs for a new insulin pump ...

Medtronic (MDT) has cut its full-year earnings outlook, citing the recent IPO of its diabetes business, MiniMed Group (MMED), and the earlier-than-expected FDA approval and commercial launch of ...

MiniMed, the insulin pump company that was born in Northridge and later folded into Medtronic, has officially come full ...

MiniMed Group Inc. is back as a locally based publicly traded company, having come full circle after 30 years. The Northridge ...

The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results ...

The latest announcement is out from Medtronic ( (MDT) ).

Medtronic reduces full-year earnings guidance following MiniMed Group IPO and one-time charge tied to Blackstone payments.

Medtronic (NYSE:MDT) said in an SEC filing that it lowered its 2026 guidance after a one-time charge related to its MiniMed ...

Under the terms of the merger agreement, Merck, through a subsidiary, will acquire all of the outstanding shares of Terns. As a result of the IPO, the company projects a total dilutive effect of $0.04 ...

March 27 (Reuters) - Medtronic said on Friday the U.S. Food and Drug Administration has cleared its surgical system for cranial and ear, nose and throat procedures, expanding the platform beyond the ...

News and commentary from the endocrinology world ...

Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...